Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Bloomington, IN MSA — September 2026
Clinical research pay surges in Bloomington as regulatory lags.
Clinical Research Associate pay hit a $133,813 metro median, nearly 50% above the $90,956 national figure, while Regulatory Affairs Specialist pay here trails the national median by roughly $36,000.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Bloomington unemployment rate: 3.7% — Up from 3.3% state rate, below 4.1% national
- CRA pay premium vs. national: +47% — $133,813 metro vs $90,956 national median
- Novo Nordisk Bloomington layoff: 400 roles — Out of ~1,800-person site, March 2026
- Indiana life sci postings, YoY: -31% — Sharp contraction vs. MA/CA life sci markets
Key takeaways
Clinical research pay in Bloomington now outpaces the nation.
The $133,813 metro median for Clinical Research Associates exceeds the $90,956 national figure by nearly 50%, a divergence unusual for a secondary metro and likely tied to IU-affiliated and hospital-based clinical trial activity competing for a thin local pool.
Regulatory affairs pay still undervalues scarcity here.
Metro Regulatory Affairs Specialist pay sits at $67,877 against a $104,000 national median, a gap that looks increasingly unsustainable given national reports of regulatory directors shifting into strategic roles and commanding premiums elsewhere.
Novo Nordisk's cuts may seed the next specialist hire.
A 400-person reduction at a facility employing 1,800 puts experienced manufacturing, quality, and process talent into local circulation, giving nearby biotech and device employers a rare window to acquire credentialed staff without the usual national bidding war.
IU's fiscal tightening is a workforce planning variable, not noise.
Tuition freezes and reduced public support at Indiana University, the metro's dominant employer, may constrain research staffing and indirectly loosen the pool of lab and technical talent that life sci employers draw from.
Median advertised pay by role — Bloomington, IN MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $115,754 | $141,396 | $160,000 | Moderate decline | $131,354 |
| Clinical Research Associate | $53,685 | $133,813 | $133,813 | Significant increase | $90,956 |
| Lab Technician * | $41,600 | $45,760 | $48,901 | Stable | $47,402 |
| Regulatory Affairs Specialist | $67,187 | $67,877 | $68,173 | Moderate increase | $104,000 |
| Clinical Data Manager * | $95,720 | $122,837 | $140,226 | Significant increase | $123,031 |
| Biostatistician * | $89,157 | $131,328 | $141,301 | Stable | $133,322 |
| Validation Engineer | $81,406 | $90,028 | $90,028 | Moderate increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Bloomington's labor market held at 3.7% unemployment in July, tighter than the national 4.1% but edging up as Indiana University's financial constraints and a tuition freeze ripple through the metro's largest employment anchor. Novo Nordisk's March reduction of 400 roles from its 1,800-person Bloomington site continues to shape local perceptions of life sci job security even as Monroe County private business establishments grew 4.6% year-over-year, suggesting a bifurcated market between large-employer caution and smaller-firm expansion.
What it means
Metro-level Clinical Research Associate pay rose sharply to a $133,813 median — well above the $90,956 national figure — which appears to reflect acute local competition for clinical talent even as Regulatory Affairs Specialist advertised pay in Bloomington lags the national median by roughly $36,000, a gap that may signal this metro is not yet pricing regulatory scarcity the way national markets are. Life sci leaders weighing build-vs-outsource decisions should treat the Novo Nordisk reduction as a potential near-term talent release into specialized manufacturing and quality roles rather than a signal of broader local demand weakness. Consider reviewing regulatory affairs compensation positioning now, before national scarcity pricing catches up to this metro and erodes any current cost advantage.
Looking ahead
Early indicator: Watch whether Novo Nordisk's March layoffs translate into measurable upticks in CMC, quality, or manufacturing applicant volume at other Bloomington-area life sci employers over the next two months.
Emerging pressure point: Indiana University's budget constraints under the tuition freeze may affect research staffing and lab technician supply; monitor IU HR postings for reductions in research-support roles that have historically fed the local talent pipeline.
Worth watching: Research Scientist advertised pay fell locally even as the national median rose 131,354, a divergence worth tracking to see if it reflects genuine demand softening or a temporary posting mix shift.
Potential inflection point: Statewide life sci job postings down 31% year-over-year could eventually reach Bloomington; a sustained decline would sharpen competition for the 170+ specialized roles recruiters report remain open across Indiana.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.